Media Advisory: OSU James Offering Free Prostate Cancer Screenings  

Share this news item:

Contact Us

For media inquiries:
614-293-3737

To find a doctor, get a referral or for information on a clinical trial:
614-293-5066
or 800-293-5066

Search for a clinical trial

Posted: 9/18/2012

COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) is offering free prostate cancer screenings from 8 a.m. to 4 p.m. on Friday (9/21), on the second floor of Ohio State’s Eye and Ear Institute, 915 Olentangy River Road.
 
Media who are interested in covering the event are asked to first contact Media Relations at 614-293-3737 to coordinate interviews with Dr. Ronney Abaza, director of robotic urologic surgery at Ohio State. Approximately 400 men are expected to be screened by receiving a digital rectal exam and a prostate-specific antigen blood test.
 
Registration is recommended for the screening, and appointments can be scheduled by call The JamesLine at 1-800-293-5066. Walk-in appointments are also available. Complimentary garage parking is provided.
 
Prostate cancer is the most common cancer in men, but it is also one of the most curable if detected early. The American Cancer Society estimates that more than 241,740 men in the United States will develop prostate cancer and more than 28,170 will die from it this year. Yearly exams are recommended for many men as one way of detecting the disease at a stage when it can be treated successfully.
 
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State’s cancer program as “exceptional,” the highest rating given by NCI survey teams. As the cancer program’s 210-bed adult patient-care component, The James is a “Top Hospital” as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S. News & World Report. 
###
 
Contact: Alexis Shaw, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737 or Alexis.Shaw2@osumc.edu


Tags: Cancer; James Cancer Hospital

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu